Awardee OrganizationSALK INSTITUTE FOR BIOLOGICAL STUDIES
Description
Abstract Text
Viral Vector Core Shared Resource - Project Summary/Abstract
(This Core was previously named the Gene Transfer, Targeting, and Therapeutics Core)
Viral vectors are commonly used to deliver genetic material to targeted cells, both in vitro and in vivo. They
also represent attractive candidates for in vivo gene therapy. However, there are significant safety concerns
when working with and producing research grade viral vectors. These safety issues are compounded when
individual research laboratories are tasked with establishing and maintaining their own safety infrastructure and
protocols. To address these concerns, the Salk Institute has established a centralized resource, namely the
Viral Vector Core. The Core produces and maintains an extensive library of commonly-used stock viral vectors.
In addition, the Core offers custom design and production services for multiple types of viral vectors, including
lentivirus, retrovirus, adenovirus, adeno-associated virus, G-deleted rabies, and vesicular stomatitis virus.
Finally, the Core provides expert consultation services, helping researchers identify the viral vector tool best
suited for their stated objectives, and teaching investigators how to safely handle and use viral vector
technologies. Salk Cancer Center members have utilized both the custom and stock vector production
services, as well as the NanoSight Particle Tracker, which is used to visualize and count nanoparticles such as
viruses and exosomes. To help Salk Cancer Center members innovate new experimental tools and potential
therapies, the Viral Vector Core constantly seeks to introduce novel viral vector technologies. Recent advances
in viral vector design have produced new AAV capsids and lentivirus/retrovirus envelope proteins with
enhanced infection and trafficking characteristics. The Core has incorporated these novel tools into Core
offerings, making them available to Cancer Center researchers. Core staff have also introduced a self-
inactivating rabies virus that has markedly less cytotoxicity, thus improving the utility of these vectors.
Public Health Relevance Statement
Data not available.
NIH Spending Category
BiotechnologyCancerGene TherapyGenetics
Project Terms
AddressAdenovirusesCancer CenterCancer Center Support GrantCapsidCellsCharacteristicsConsultationsCustomDependovirusEducational process of instructingGene TransferGenetic MaterialsIn VitroIndividualInfectionInfrastructureInstitutesLaboratory ResearchLentivirusLibrariesNamesPreparationProductionProtocols documentationRabiesRabies virusReporterResearchResearch PersonnelResource SharingResourcesRetroviridaeSafetyServicesSourceTechnologyTrainingVesicular stomatitis Indiana virusViral VectorViruscytotoxicitydesignenv Gene Productsexosomegene therapyimprovedin vivoinnovationmembernanoparticlenovelparticletargeted treatmenttooltraffickingvector
No Sub Projects information available for 5P30CA014195-49 6493
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30CA014195-49 6493
Patents
No Patents information available for 5P30CA014195-49 6493
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30CA014195-49 6493
Clinical Studies
No Clinical Studies information available for 5P30CA014195-49 6493
News and More
Related News Releases
No news release information available for 5P30CA014195-49 6493
History
No Historical information available for 5P30CA014195-49 6493
Similar Projects
No Similar Projects information available for 5P30CA014195-49 6493